Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Part B Oral Rx Dispensing Fee Is $10 Under Proposed Rule

Executive Summary

The Centers for Medicare & Medicaid Services will pay a $10 dispensing fee to pharmacies for the handful of oral drugs covered under Medicare Part B

You may also be interested in...



Faslodex, Aranesp Have Special Status Under Hospital Payment Rule

CMS is proposing to allow separate Medicare payments for Faslodex, Trelstar and argatroban use in the hospital outpatient setting when the products become ineligible for "pass-through" payments in 2005

Faslodex, Aranesp Have Special Status Under Hospital Payment Rule

CMS is proposing to allow separate Medicare payments for Faslodex, Trelstar and argatroban use in the hospital outpatient setting when the products become ineligible for "pass-through" payments in 2005

Inhalation Rx Market In Transition; CMS May Increase 2005 Payments

The Center for Medicare & Medicaid Services is inviting comment on how best to manage the transition of the inhalation therapy market ahead of the outpatient Medicare prescription drug benefit beginning in 2006

Related Content

Topics

UsernamePublicRestriction

Register

PS044432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel